{"id":"https://openalex.org/W69753163","doi":null,"title":"Antitumor effects of mutant endostatin are enhanced by Bcl-2 antisense oligonucleotides in UM-UC-3 bladder cancer cell line.","display_name":"Antitumor effects of mutant endostatin are enhanced by Bcl-2 antisense oligonucleotides in UM-UC-3 bladder cancer cell line.","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W69753163","mag":"69753163","pmid":"https://pubmed.ncbi.nlm.nih.gov/23924452"},"language":"en","primary_location":{"id":"pmid:23924452","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23924452","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chinese medical journal","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021472496","display_name":"Ming-Hua Ren","orcid":"https://orcid.org/0009-0004-1602-5146","observed_orcids":["https://orcid.org/0009-0004-1602-5146","https://orcid.org/0000-0001-8736-1180"]},"institutions":[{"id":"https://openalex.org/I156144747","display_name":"Harbin Medical University","ror":"https://ror.org/05jscf583","country_code":"CN","type":"education","lineage":["https://openalex.org/I156144747"]},{"id":"https://openalex.org/I4210156501","display_name":"First Affiliated Hospital of Harbin Medical University","ror":"https://ror.org/05vy2sc54","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156501"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Ming-hua Ren","raw_affiliation_strings":["Department of Urinary Surgery, First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang 150001, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urinary Surgery, First Affiliated Hospital, Harbin Medical University, Harbin, Heilongjiang 150001, China","institution_ids":["https://openalex.org/I156144747","https://openalex.org/I4210156501"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014625839","display_name":"Jing-song Yu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing-song Yu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037099172","display_name":"Erlin Song","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Er-lin Song","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100439606","display_name":"Cheng Zhang","orcid":"https://orcid.org/0000-0001-8932-0585","observed_orcids":["https://orcid.org/0000-0001-8932-0585"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cheng Zhang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100706321","display_name":"Li Ma","orcid":"https://orcid.org/0009-0009-5892-228X","observed_orcids":["https://orcid.org/0009-0009-5892-228X","https://orcid.org/0000-0003-4093-4791"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Li Ma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019319860","display_name":"Zhi-xing Jiao","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhi-xing Jiao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100694248","display_name":"Weiming Zhao","orcid":"https://orcid.org/0000-0001-8977-0519","observed_orcids":["https://orcid.org/0000-0001-8977-0519"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wei-ming Zhao","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032717500","display_name":"Yujuan Shan","orcid":"https://orcid.org/0000-0002-7439-6365","observed_orcids":["https://orcid.org/0000-0002-7439-6365"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yu-juan Shan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5006673829","display_name":"Shaobin Ni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shao-bin Ni","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.00457241,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"126","issue":"15","first_page":"2834","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9096999764442444,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9096999764442444,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.041200000792741776,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.02459999918937683,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bcl-2-antisense-oligonucleotide","display_name":"Bcl-2 antisense oligonucleotide","score":0.9559999704360962},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.8489999771118164},{"id":"https://openalex.org/keywords/umuc3-cells","display_name":"UMUC3 cells","score":0.9440000057220459},{"id":"https://openalex.org/keywords/tumor-angiogenesis-inhibition","display_name":"tumor angiogenesis inhibition","score":0.9049999713897705},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.6169999837875366},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9520000219345093},{"id":"https://openalex.org/keywords/synergistic-antitumor-effect","display_name":"synergistic antitumor effect","score":0.8629999756813049},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8220000267028809}],"concepts":[{"id":"https://openalex.org/C75920679","wikidata":"https://www.wikidata.org/wiki/Q359012","display_name":"Endostatin","level":3,"score":0.7318946123123169},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.6967111229896545},{"id":"https://openalex.org/C49923114","wikidata":"https://www.wikidata.org/wiki/Q17139621","display_name":"Lipofectamine","level":5,"score":0.6595981121063232},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.6489792466163635},{"id":"https://openalex.org/C88634738","wikidata":"https://www.wikidata.org/wiki/Q24769543","display_name":"Annexin","level":3,"score":0.5817590951919556},{"id":"https://openalex.org/C2780783641","wikidata":"https://www.wikidata.org/wiki/Q738686","display_name":"MTT assay","level":3,"score":0.5340297222137451},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5152685642242432},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.46289223432540894},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.4625726342201233},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4555138945579529},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4543069005012512},{"id":"https://openalex.org/C129312508","wikidata":"https://www.wikidata.org/wiki/Q133686","display_name":"Oligonucleotide","level":3,"score":0.43639498949050903},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4146631956100464},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3682118058204651},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14457657933235168},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.14390665292739868},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.1164340078830719},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C92087593","wikidata":"https://www.wikidata.org/wiki/Q427389","display_name":"Vector (molecular biology)","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C40767141","wikidata":"https://www.wikidata.org/wiki/Q285697","display_name":"Recombinant DNA","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D004357","descriptor_name":"Drug Synergism","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013873","descriptor_name":"Thionucleotides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D043169","descriptor_name":"Endostatins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:23924452","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23924452","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Chinese medical journal","raw_type":"Journal Article"},{"id":"mag:69753163","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23924452","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2391632821","https://openalex.org/W2123753866","https://openalex.org/W3031369225","https://openalex.org/W2060036770","https://openalex.org/W2010546657","https://openalex.org/W2378797806","https://openalex.org/W2007709760","https://openalex.org/W2012701502","https://openalex.org/W2379984914","https://openalex.org/W2350464416"],"abstract_inverted_index":{"BACKGROUND:":[0],"Endostatin":[1],"is":[2],"a":[3,15,51],"potent":[4],"inhibitor":[5],"of":[6,30,108,114,136,152,163,214,236,250],"tumor":[7,70,109,116,217],"angiogenesis.":[8],"In":[9,22,90,179],"the":[10,27,58,69,84,91,106,115,119,133,137,146,153,164,180,194,200,212,215,220,233,247],"preliminary":[11],"studies,":[12],"we":[13,25],"developed":[14],"mutant":[16,31,237,256],"endostatin":[17,32,238],"containing":[18],"Arg-Gly-Asp-Arg-Gly-Asp":[19],"(RGDRGD)":[20],"sequences.":[21],"this":[23],"study,":[24,94],"compared":[26,144],"antitumor":[28,234],"effects":[29,203,235,249],"and":[33,40,54,83,105,121,167,174,188,242],"Bcl-2":[34,46,229,251],"antisense":[35,230,252],"oligonucleotides":[36,231,253],"both":[37,239],"in":[38,92,118,211,219,221,240,243],"combination":[39,139,155],"individually.":[41],"METHODS:":[42],"The":[43,112,127,149],"artificially":[44],"synthesized":[45],"ASODN":[47,166],"(antisense":[48],"oligonucleotides)":[49],"included":[50],"translation-initiation":[52],"site":[53],"was":[55,66,110,157,197],"transfected":[56],"into":[57,102],"bladder":[59,96],"cancer":[60,97],"cells":[61,98],"by":[62,68,142],"Lipofectamine.":[63],"Cell":[64],"growth":[65,72,107,129,218],"investigated":[67],"cell":[71,128,134],"chart,":[73],"MTT":[74],"assay,":[75,79,193],"caspase-3":[76,181],"activity":[77,182],"detection":[78,88,183,192],"AO/EB":[80,185],"fluorescein":[81,186],"stain,":[82],"annexin":[85,189],"V-FITC":[86,190],"apoptosis":[87,191],"assay.":[89],"vivo":[93,222],"UM-UC-3":[95],"were":[99,124,170,208],"subcutaneously":[100],"implanted":[101],"nude":[103],"mice":[104],"examined.":[111],"ultrastructure":[113],"tissues":[117],"treated":[120,138,154],"control":[122,147],"groups":[123,169],"observed.":[125],"RESULTS:":[126],"chart":[130],"showed":[131],"that":[132,228],"population":[135],"group":[140,156],"decreased":[141],"52.04%":[143],"to":[145],"group.":[148],"inhibition":[150,213],"rate":[151],"(79.66":[158],"\u00b1":[159,172,176],"6.79)%,":[160],"whereas":[161],"those":[162],"individual":[165,201],"ES":[168],"(53.39":[171],"3.22)%":[173],"(50.22":[175],"5.46)%":[177],"respectively.":[178],"using":[184],"stain":[187],"co-inhibitory":[195],"effect":[196],"higher":[198],"than":[199],"inhibitory":[202],"(P":[204],"<":[205],"0.05).":[206],"There":[207],"significant":[209],"differences":[210],"solid":[216],"study.":[223],"CONCLUSIONS:":[224],"Our":[225],"findings":[226],"indicated":[227],"enhance":[232],"vitro":[241],"vivo.":[244],"We":[245],"noted":[246],"synergistic":[248],"combined":[254],"with":[255],"endostatin.":[257]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}